Y-mAbs Therapeutics, Inc. (YMAB)

USD 4.48

(-3.86%)

Total Liabilities Summary of Y-mAbs Therapeutics, Inc.

  • Y-mAbs Therapeutics, Inc.'s latest annual total liabilities in 2023 was 26.88 Million USD , down -16.6% from previous year.
  • Y-mAbs Therapeutics, Inc.'s latest quarterly total liabilities in 2024 Q2 was 48.69 Million USD , up 101.85% from previous quarter.
  • Y-mAbs Therapeutics, Inc. reported annual total liabilities of 32.23 Million USD in 2022, down -1.35% from previous year.
  • Y-mAbs Therapeutics, Inc. reported annual total liabilities of 32.67 Million USD in 2021, up 24.67% from previous year.
  • Y-mAbs Therapeutics, Inc. reported quarterly total liabilities of 24.12 Million USD for 2024 Q1, down -10.26% from previous quarter.
  • Y-mAbs Therapeutics, Inc. reported quarterly total liabilities of 26.88 Million USD for 2023 FY, down -16.6% from previous quarter.

Annual Total Liabilities Chart of Y-mAbs Therapeutics, Inc. (2023 - 2016)

Historical Annual Total Liabilities of Y-mAbs Therapeutics, Inc. (2023 - 2016)

Year Total Liabilities Total Liabilities Growth
2023 26.88 Million USD -16.6%
2022 32.23 Million USD -1.35%
2021 32.67 Million USD 24.67%
2020 26.21 Million USD 50.09%
2019 17.46 Million USD 53.22%
2018 11.39 Million USD 14.26%
2017 9.97 Million USD 91.83%
2016 5.2 Million USD 0.0%

Peer Total Liabilities Comparison of Y-mAbs Therapeutics, Inc.

Name Total Liabilities Total Liabilities Difference
AbCellera Biologics Inc. 335.77 Million USD 91.993%
Alkermes plc 933.53 Million USD 97.12%
Agenus Inc. 462.29 Million USD 94.185%
Alnylam Pharmaceuticals, Inc. 4.05 Billion USD 99.336%
Aptorum Group Limited 5.25 Million USD -411.42%
Ardelyx, Inc. 130.76 Million USD 79.441%
Arrowhead Pharmaceuticals, Inc. 478.39 Million USD 94.38%
Bicycle Therapeutics plc 224.41 Million USD 88.02%
BioXcel Therapeutics, Inc. 130.21 Million USD 79.353%
ChromaDex Corporation 26.5 Million USD -1.418%
Chimerix, Inc. 19.74 Million USD -36.156%
Corbus Pharmaceuticals Holdings, Inc. 35.17 Million USD 23.575%
Caribou Biosciences, Inc. 72.56 Million USD 62.953%
CRISPR Therapeutics AG 346.76 Million USD 92.247%
Precision BioSciences, Inc. 140.92 Million USD 80.923%
Dyadic International, Inc. 2.34 Million USD -1048.569%
Eton Pharmaceuticals, Inc. 16.26 Million USD -65.308%
Fortress Biotech, Inc. 165.93 Million USD 83.799%
Lantern Pharma Inc. 2.73 Million USD -881.282%
HOOKIPA Pharma Inc. 71.48 Million USD 62.389%
Inhibikase Therapeutics, Inc. 3.52 Million USD -661.862%
Incyte Corporation 1.59 Billion USD 98.312%
IO Biotech, Inc. 17.55 Million USD -53.133%
Jaguar Health, Inc. 45.86 Million USD 41.386%
Novavax, Inc. 2.57 Billion USD 98.955%
Janux Therapeutics, Inc. 36.05 Million USD 25.442%
Opthea Limited 264.6 Million USD 89.84%
Ligand Pharmaceuticals Incorporated 130.7 Million USD 79.432%
ContextLogic Inc. 206 Million USD 86.95%
MiMedx Group, Inc. 96.33 Million USD 72.092%
Pyxis Oncology, Inc. 48.02 Million USD 44.017%
TransCode Therapeutics, Inc. 3.52 Million USD -661.827%
NextCure, Inc. 14.99 Million USD -79.263%
Ocuphire Pharma, Inc. 4.04 Million USD -565.116%
Oncternal Therapeutics, Inc. 6.67 Million USD -302.636%
Outlook Therapeutics, Inc. 46.73 Million USD 42.481%
Vaxcyte, Inc. 167.44 Million USD 83.945%
PDS Biotechnology Corporation 33.25 Million USD 19.168%
Madrigal Pharmaceuticals, Inc. 235.21 Million USD 88.57%
Pharming Group N.V. 244.07 Million USD 88.985%
Pieris Pharmaceuticals, Inc. 11.92 Million USD -125.499%
Avidity Biosciences, Inc. 127.79 Million USD 78.963%
Reviva Pharmaceuticals Holdings, Inc. 6.6 Million USD -306.885%
Reviva Pharmaceuticals Holdings, Inc. 6.6 Million USD -306.885%
Sangamo Therapeutics, Inc. 82.43 Million USD 67.387%
Sol-Gel Technologies Ltd. 6.64 Million USD -304.697%
Acelyrin, Inc. 86.35 Million USD 68.867%
Salarius Pharmaceuticals, Inc. 1.29 Million USD -1969.208%
SELLAS Life Sciences Group, Inc. 14.37 Million USD -86.967%
Summit Therapeutics Inc. 125.25 Million USD 78.537%
Sensei Biotherapeutics, Inc. 9.47 Million USD -183.616%
Senti Biosciences, Inc. 52.57 Million USD 48.862%
Stoke Therapeutics, Inc. 68.77 Million USD 60.911%
Syros Pharmaceuticals, Inc. 151.51 Million USD 82.256%
Alaunos Therapeutics, Inc. 1.95 Million USD -1274.438%
Telomir Pharmaceuticals, Inc. Common Stock 1.33 Million USD -1912.932%
Entrada Therapeutics, Inc. 226.83 Million USD 88.148%
VistaGen Therapeutics, Inc. 9.36 Million USD -187.008%
Wave Life Sciences Ltd. 227.44 Million USD 88.18%
Sorrento Therapeutics, Inc. 494.5 Million USD 94.563%
TRACON Pharmaceuticals, Inc. 10.91 Million USD -146.326%
Barinthus Biotherapeutics plc 27.51 Million USD 2.279%
Psyence Biomedical Ltd. 12.1 Million USD -122.096%
Phathom Pharmaceuticals, Inc. 486.6 Million USD 94.475%
Immix Biopharma, Inc. 3.72 Million USD -622.342%
Keros Therapeutics, Inc. 37.81 Million USD 28.901%
MEI Pharma, Inc. 8.35 Million USD -221.771%
Windtree Therapeutics, Inc. 29.01 Million USD 7.344%
Xeris Biopharma Holdings, Inc. 347.58 Million USD 92.265%
Rigel Pharmaceuticals, Inc. 145.86 Million USD 81.57%
Fortress Biotech, Inc. 165.93 Million USD 83.799%
Precigen, Inc. 41.64 Million USD 35.443%
Clearside Biomedical, Inc. 49.93 Million USD 46.157%
AlloVir, Inc. 45.01 Million USD 40.278%
C4 Therapeutics, Inc. 130.33 Million USD 79.373%
Fate Therapeutics, Inc. 137.8 Million USD 80.491%
ImmuCell Corporation 18.81 Million USD -42.886%
IDEAYA Biosciences, Inc. 28.22 Million USD 4.754%
Onconetix, Inc. 23.18 Million USD -15.975%
PureTech Health plc 125.58 Million USD 78.593%
VYNE Therapeutics Inc. 8.95 Million USD -200.38%
Elevation Oncology, Inc. 34.28 Million USD 21.58%
Kintara Therapeutics, Inc. 2.44 Million USD -999.55%
Seer, Inc. 39.36 Million USD 31.706%
Verrica Pharmaceuticals Inc. 61.83 Million USD 56.522%
Innoviva, Inc. 568.55 Million USD 95.271%
Aadi Bioscience, Inc. 27.22 Million USD 1.263%
ESSA Pharma Inc. 3.49 Million USD -669.198%
GlycoMimetics, Inc. 6.9 Million USD -289.506%
GT Biopharma, Inc. 6.63 Million USD -305.307%
Inhibrx Biosciences, Inc. 264.39 Million USD 89.832%
Akebia Therapeutics, Inc. 272.28 Million USD 90.127%
Catalyst Pharmaceuticals, Inc. 84.02 Million USD 68.005%
Longboard Pharmaceuticals, Inc. 9.77 Million USD -175.056%
Orchestra BioMed Holdings, Inc. 27.16 Million USD 1.049%
Alzamend Neuro, Inc. 3.22 Million USD -733.413%
Rocket Pharmaceuticals, Inc. 73.76 Million USD 63.556%
Aptose Biosciences Inc. 15.8 Million USD -70.058%
ZyVersa Therapeutics, Inc. 11.03 Million USD -143.521%
Soligenix, Inc. 7.27 Million USD -269.544%
Century Therapeutics, Inc. 175.94 Million USD 84.72%
Kura Oncology, Inc. 51.66 Million USD 47.962%
TScan Therapeutics, Inc. 121.28 Million USD 77.833%
Intensity Therapeutics, Inc. 4.13 Million USD -550.472%
Ocean Biomedical, Inc. 6.61 Million USD -306.48%
CytomX Therapeutics, Inc. 252.59 Million USD 89.357%
Autolus Therapeutics plc 263.9 Million USD 89.813%
Mineralys Therapeutics, Inc. 10.48 Million USD -156.478%
EyePoint Pharmaceuticals, Inc. 88.86 Million USD 69.746%
Eterna Therapeutics Inc. 46.89 Million USD 42.677%
Adaptive Biotechnologies Corporation 352.85 Million USD 92.381%
GRI Bio, Inc. 2.69 Million USD -896.811%
Xenetic Biosciences, Inc. 809.58 Thousand USD -3220.714%
Tenaya Therapeutics, Inc. 31.09 Million USD 13.531%
IGM Biosciences, Inc. 220.17 Million USD 87.79%
INmune Bio, Inc. 18.86 Million USD -42.53%
Heron Therapeutics, Inc. 256.47 Million USD 89.518%
SAB Biotherapeutics, Inc. 26.64 Million USD -0.909%
Pasithea Therapeutics Corp. 2.71 Million USD -888.962%
Entero Therapeutics, Inc. 3.28 Million USD -719.568%
Milestone Pharmaceuticals Inc. 58.45 Million USD 54.009%
X4 Pharmaceuticals, Inc. 96.15 Million USD 72.042%
Atara Biotherapeutics, Inc. 264.73 Million USD 89.845%
Coherus BioSciences, Inc. 823.02 Million USD 96.734%
Verastem, Inc. 71.18 Million USD 62.234%
Abeona Therapeutics Inc. 49.17 Million USD 45.331%
Pliant Therapeutics, Inc. 38.57 Million USD 30.313%
Tonix Pharmaceuticals Holding Corp. 48.93 Million USD 45.058%
Histogen Inc. 5.69 Million USD -371.897%
Aprea Therapeutics, Inc. 4.38 Million USD -513.006%
Surrozen, Inc. 8.14 Million USD -230.068%
Organovo Holdings, Inc. 2.74 Million USD -878.311%
Lixte Biotechnology Holdings, Inc. 313.85 Thousand USD -8465.657%
Ovid Therapeutics Inc. 56.22 Million USD 52.189%
Panbela Therapeutics, Inc. 16.51 Million USD -62.815%
CASI Pharmaceuticals, Inc. 51.1 Million USD 47.393%
Cadrenal Therapeutics, Inc. Common Stock 826.87 Thousand USD -3151.277%
Centessa Pharmaceuticals plc 126.72 Million USD 78.786%
Hepion Pharmaceuticals, Inc. 10.81 Million USD -148.613%
Arcturus Therapeutics Holdings Inc. 150.88 Million USD 82.183%
BioRestorative Therapies, Inc. 2.6 Million USD -931.087%
Apollomics, Inc. 14.15 Million USD -89.953%
Amarin Corporation plc 279.58 Million USD 90.384%
Mesoblast Limited 188.79 Million USD 85.76%
Turnstone Biologics Corp. 14.14 Million USD -90.02%
Kymera Therapeutics, Inc. 180.78 Million USD 85.13%
Synaptogenix, Inc. 5.52 Million USD -386.195%
Tiziana Life Sciences Ltd 6.64 Million USD -304.392%
Aurinia Pharmaceuticals Inc. 170.1 Million USD 84.196%
BriaCell Therapeutics Corp. 8.55 Million USD -214.168%
Monopar Therapeutics Inc. 1.75 Million USD -1429.766%
Exelixis, Inc. 678.44 Million USD 96.037%
Better Therapeutics, Inc. 23.84 Million USD -12.759%
Nurix Therapeutics, Inc. 164.04 Million USD 83.612%
Apellis Pharmaceuticals, Inc. 594.2 Million USD 95.476%
NLS Pharmaceutics AG 10.68 Million USD -151.718%
Dermata Therapeutics, Inc. 1.62 Million USD -1555.81%
Aridis Pharmaceuticals, Inc. 38.92 Million USD 30.937%
Gritstone bio, Inc. 125.91 Million USD 78.65%
Jasper Therapeutics, Inc. 14.67 Million USD -83.183%
TNF Pharmaceuticals, Inc. 5.08 Million USD -428.315%
Avid Bioservices, Inc. 275.66 Million USD 90.248%
Insmed Incorporated 1.66 Billion USD 98.382%
Virpax Pharmaceuticals, Inc. 7.69 Million USD -249.414%
MediWound Ltd. 27.18 Million USD 1.115%
OmniAb, Inc. 87.4 Million USD 69.24%
Alector, Inc. 487.66 Million USD 94.487%
Seres Therapeutics, Inc. 403.45 Million USD 93.337%
Checkpoint Therapeutics, Inc. 18.42 Million USD -45.91%
Viracta Therapeutics, Inc. 38.37 Million USD 29.94%
Zai Lab Limited 240.17 Million USD 88.807%
Revance Therapeutics, Inc. 630.05 Million USD 95.733%
Aura Biosciences, Inc. 29.22 Million USD 8.017%
Lyell Immunopharma, Inc. 95.07 Million USD 71.724%
Immunic, Inc. 25.36 Million USD -5.976%
Tarsus Pharmaceuticals, Inc. 69.23 Million USD 61.17%
Veracyte, Inc. 93.71 Million USD 71.314%
InMed Pharmaceuticals Inc. 2.61 Million USD -927.412%
FibroGen, Inc. 585.72 Million USD 95.41%
SeaStar Medical Holding Corporation 17.38 Million USD -54.657%
Adial Pharmaceuticals, Inc. 653.07 Thousand USD -4016.519%
Sonnet BioTherapeutics Holdings, Inc. 5.65 Million USD -375.364%
Jazz Pharmaceuticals plc 7.65 Billion USD 99.649%
Cyclacel Pharmaceuticals, Inc. 8.19 Million USD -227.934%
Amylyx Pharmaceuticals, Inc. 84.02 Million USD 68.004%
TG Therapeutics, Inc. 169.08 Million USD 84.1%
Galecto, Inc. 5.89 Million USD -355.97%
Calithera Biosciences, Inc. 8.28 Million USD -224.529%
Fortrea Holdings Inc. 2.61 Billion USD 98.973%
KalVista Pharmaceuticals, Inc. 28.82 Million USD 6.724%
Aptevo Therapeutics Inc. 12.62 Million USD -113.01%
XBiotech Inc. 8.39 Million USD -220.162%
Jasper Therapeutics, Inc. 14.67 Million USD -83.183%
Lyra Therapeutics, Inc. 53.18 Million USD 49.447%
Foghorn Therapeutics Inc. 363.1 Million USD 92.596%
Theravance Biopharma, Inc. 169 Million USD 84.093%
Ultragenyx Pharmaceutical Inc. 1.21 Billion USD 97.788%
Metagenomi, Inc. Common Stock 500.42 Million USD 94.628%
Vaxxinity, Inc. 30.94 Million USD 13.12%
BioCryst Pharmaceuticals, Inc. 972.48 Million USD 97.236%
Gain Therapeutics, Inc. 6.03 Million USD -345.756%
Cartesian Therapeutics, Inc. 745.23 Million USD 96.393%
NexImmune, Inc. 5.08 Million USD -428.772%
Creative Medical Technology Holdings, Inc. 371.39 Thousand USD -7138.674%
Marker Therapeutics, Inc. 3.07 Million USD -774.32%
Regeneron Pharmaceuticals, Inc. 7.1 Billion USD 99.622%
Chemomab Therapeutics Ltd. 5.15 Million USD -421.611%
Scopus BioPharma Inc. 7.45 Million USD -260.644%
RAPT Therapeutics, Inc. 26.29 Million USD -2.244%
Ainos, Inc. 7.39 Million USD -263.581%
Pluri Inc. 34.11 Million USD 21.189%
Prothena Corporation plc 135.01 Million USD 80.088%
Adaptimmune Therapeutics plc 243.1 Million USD 88.941%
Celularity Inc. 102.92 Million USD 73.881%
Rallybio Corporation 9.43 Million USD -184.909%
Cue Biopharma, Inc. 24.44 Million USD -9.978%
MeiraGTx Holdings plc 319.99 Million USD 91.599%
Omeros Corporation 403.25 Million USD 93.333%
Humacyte, Inc. 114.67 Million USD 76.557%
Immunocore Holdings plc 228.15 Million USD 88.217%
Cocrystal Pharma, Inc. 4.87 Million USD -451.467%
Cidara Therapeutics, Inc. 76.74 Million USD 64.967%
Blueprint Medicines Corporation 918.64 Million USD 97.074%
CalciMedica, Inc. 4.02 Million USD -567.428%
Cabaletta Bio, Inc. 17.45 Million USD -54.045%
Marinus Pharmaceuticals, Inc. 154.14 Million USD 82.559%
Scholar Rock Holding Corporation 85.81 Million USD 68.673%
Sana Biotechnology, Inc. 277.79 Million USD 90.322%
Pulmatrix, Inc. 15.96 Million USD -68.414%
Elicio Therapeutics, Inc. 15.77 Million USD -70.443%
Vigil Neuroscience, Inc. 24.6 Million USD -9.258%
Intellia Therapeutics, Inc. 250.8 Million USD 89.281%
Adlai Nortye Ltd. American Depositary Shares 50.78 Million USD 47.064%
Cytokinetics, Incorporated 1.21 Billion USD 97.779%
Eloxx Pharmaceuticals, Inc. 31.78 Million USD 15.414%
Nutriband Inc. 1.07 Million USD -2391.753%
Protara Therapeutics, Inc. 10.63 Million USD -152.836%
Vor Biopharma Inc. 59.1 Million USD 54.514%
Roivant Sciences Ltd. 773.95 Million USD 96.526%
Evogene Ltd. 17.99 Million USD -49.439%
ProKidney Corp. 29.21 Million USD 7.982%
Applied Therapeutics, Inc. 71.97 Million USD 62.65%
Hoth Therapeutics, Inc. 704.98 Thousand USD -3713.425%
BridgeBio Pharma, Inc. 1.88 Billion USD 98.577%
CorMedix Inc. 11.91 Million USD -125.584%
BioLineRx Ltd. 50.7 Million USD 46.976%
Tango Therapeutics, Inc. 149.45 Million USD 82.012%
Galectin Therapeutics Inc. 88.44 Million USD 69.602%
Atai Life Sciences N.V. 49.16 Million USD 45.315%
Renovaro Biosciences Inc. 31.15 Million USD 13.701%
Aerovate Therapeutics, Inc. 17.96 Million USD -49.672%
Zentalis Pharmaceuticals, Inc. 124.63 Million USD 78.43%
Sagimet Biosciences Inc. 5.65 Million USD -375.486%
MediciNova, Inc. 3.89 Million USD -590.83%
Praxis Precision Medicines, Inc. 18.27 Million USD -47.076%
Cardio Diagnostics Holdings, Inc. 1.5 Million USD -1687.214%
GeoVax Labs, Inc. 3.51 Million USD -663.776%
Axsome Therapeutics, Inc. 397.25 Million USD 93.233%
Biomea Fusion, Inc. 30.69 Million USD 12.401%
PTC Therapeutics, Inc. 2.72 Billion USD 99.012%
Mereo BioPharma Group plc 15.96 Million USD -68.425%
Cullinan Oncology, Inc. 31.2 Million USD 13.836%
Syndax Pharmaceuticals, Inc. 58.68 Million USD 54.189%
Absci Corporation 58.3 Million USD 53.89%
NRx Pharmaceuticals, Inc. 19.04 Million USD -41.138%
4D Molecular Therapeutics, Inc. 32.06 Million USD 16.15%
Dyne Therapeutics, Inc. 73.79 Million USD 63.567%
Kiniksa Pharmaceuticals, Ltd. 87.48 Million USD 69.269%
Ventyx Biosciences, Inc. 33.77 Million USD 20.391%
Allakos Inc. 74.79 Million USD 64.055%
Imunon, Inc. 8.53 Million USD -215.154%
Fulcrum Therapeutics, Inc. 22.5 Million USD -19.479%
Corcept Therapeutics Incorporated 114.81 Million USD 76.584%
BioAtla, Inc. 48.98 Million USD 45.119%
NLS Pharmaceutics AG 10.68 Million USD -151.718%
Bio-Path Holdings, Inc. 2.77 Million USD -867.398%
Allogene Therapeutics, Inc. 130.6 Million USD 79.416%
Larimar Therapeutics, Inc. 14.21 Million USD -89.124%
XOMA Corporation 145.58 Million USD 81.533%
Kezar Life Sciences, Inc. 33.66 Million USD 20.143%
Cara Therapeutics, Inc. 68.75 Million USD 60.901%
aTyr Pharma, Inc. 31.59 Million USD 14.916%
Aligos Therapeutics, Inc. 61.82 Million USD 56.515%
Akero Therapeutics, Inc. 44.96 Million USD 40.211%
Viridian Therapeutics, Inc. 48.4 Million USD 44.457%
Eliem Therapeutics, Inc. 2.87 Million USD -836.725%
EyeGate Pharmaceuticals, Inc. 8.15 Million USD -229.541%
Akari Therapeutics, Plc 4.58 Million USD -486.475%
Tevogen Bio Holdings Inc. 17.73 Million USD -51.603%
Halozyme Therapeutics, Inc. 1.64 Billion USD 98.37%
Lexaria Bioscience Corp. 403.9 Thousand USD -6555.971%
UroGen Pharma Ltd. 243.52 Million USD 88.96%
Sutro Biopharma, Inc. 321.08 Million USD 91.627%
ZIVO Bioscience, Inc. 2.76 Million USD -873.508%
Orgenesis Inc. 35.53 Million USD 24.345%
Entera Bio Ltd. 1.37 Million USD -1849.529%
GH Research PLC 6.7 Million USD -301.194%
Lisata Therapeutics, Inc. 6.8 Million USD -295.353%
Reneo Pharmaceuticals, Inc. 18.82 Million USD -42.803%
Xencor, Inc. 283.55 Million USD 90.519%
60 Degrees Pharmaceuticals, Inc. 2.98 Million USD -800.433%
Replimune Group, Inc. 113.21 Million USD 76.254%
Coeptis Therapeutics Holdings, Inc. 3.75 Million USD -615.547%
Vanda Pharmaceuticals Inc. 103.53 Million USD 74.033%
Lexaria Bioscience Corp. 403.9 Thousand USD -6555.971%
Portage Biotech Inc. 4.45 Million USD -504.135%
Cardio Diagnostics Holdings, Inc. 1.5 Million USD -1687.214%
Olema Pharmaceuticals, Inc. 23.05 Million USD -16.633%
OncoCyte Corporation 49.29 Million USD 45.466%
Qualigen Therapeutics, Inc. 4.13 Million USD -549.874%
Processa Pharmaceuticals, Inc. 797.48 Thousand USD -3271.102%
Purple Biotech Ltd. 10 Million USD -168.706%
CollPlant Biotechnologies Ltd. 5.78 Million USD -364.639%
scPharmaceuticals Inc. 57.26 Million USD 53.05%
ProMIS Neurosciences, Inc. 12.38 Million USD -117.016%
HilleVax, Inc. 78.9 Million USD 65.93%
NeuroSense Therapeutics Ltd. 5.05 Million USD -432.356%
Tharimmune, Inc. 1.81 Million USD -1381.175%
Genprex, Inc. 3.25 Million USD -726.13%
Neumora Therapeutics, Inc. Common Stock 27.11 Million USD 0.867%
Atossa Therapeutics, Inc. 5.23 Million USD -413.445%
XTL Biopharmaceuticals Ltd. 206 Thousand USD -12950.485%
Virios Therapeutics, Inc. 358.54 Thousand USD -7398.02%
OKYO Pharma Limited 7.42 Million USD -262.277%
Savara Inc. 37.19 Million USD 27.716%
Curis, Inc. 57.61 Million USD 53.336%
Daré Bioscience, Inc. 26.32 Million USD -2.105%
Carmell Therapeutics Corporation 39.19 Million USD 31.418%
Titan Pharmaceuticals, Inc. 1.44 Million USD -1761.773%
Achieve Life Sciences, Inc. 20.81 Million USD -29.132%
BeiGene, Ltd. 2.23 Billion USD 98.796%
Kiromic BioPharma, Inc. 21.28 Million USD -26.276%
Revolution Medicines, Inc. Warrant 262.39 Million USD 89.754%
Protagonist Therapeutics, Inc. 21.27 Million USD -26.37%
Erasca, Inc. 78.61 Million USD 65.801%
bluebird bio, Inc. 424.62 Million USD 93.669%
Protagenic Therapeutics, Inc. 655.25 Thousand USD -4002.849%
BioMarin Pharmaceutical Inc. 1.89 Billion USD 98.578%
DBV Technologies S.A. 42.8 Million USD 37.187%
Protagenic Therapeutics, Inc. 655.25 Thousand USD -4002.849%
Moderna, Inc. 4.57 Billion USD 99.412%
Vincerx Pharma, Inc. 6.99 Million USD -284.332%
Fresh Tracks Therapeutics, Inc. 1.65 Million USD -1523.43%
Molecular Templates, Inc. 31.17 Million USD 13.753%
Acrivon Therapeutics, Inc. Common Stock 17.07 Million USD -57.493%
Travere Therapeutics, Inc. 588.1 Million USD 95.429%
Monte Rosa Therapeutics, Inc. 124.5 Million USD 78.407%
Spruce Biosciences, Inc. 27.43 Million USD 2.016%
Celldex Therapeutics, Inc. 36.45 Million USD 26.256%
Cogent Biosciences, Inc. 55.63 Million USD 51.678%
MacroGenics, Inc. 154.2 Million USD 82.566%
RenovoRx, Inc. 4.46 Million USD -501.97%
Adicet Bio, Inc. 37.12 Million USD 27.575%
Prime Medicine, Inc. 60.78 Million USD 55.768%
Aditxt, Inc. 28.53 Million USD 5.775%
Adagene Inc. 45.16 Million USD 40.482%
Estrella Immunopharma, Inc. 180.7 Thousand USD -14777.616%
Quantum-Si incorporated 26.63 Million USD -0.95%
Maravai LifeSciences Holdings, Inc. 697.56 Million USD 96.146%
Acurx Pharmaceuticals, Inc. 3.04 Million USD -783.633%
Voyager Therapeutics, Inc. 114.96 Million USD 76.615%
SciSparc Ltd. 1.59 Million USD -1585.517%
Vericel Corporation 127.7 Million USD 78.948%
Revelation Biosciences, Inc. 5.56 Million USD -383.1%
Minerva Neurosciences, Inc. 85.35 Million USD 68.504%
Generation Bio Co. 171.63 Million USD 84.336%
Astria Therapeutics, Inc. 11.55 Million USD -132.762%
Black Diamond Therapeutics, Inc. 41.83 Million USD 35.732%
Arcutis Biotherapeutics, Inc. 252.69 Million USD 89.361%
Invivyd, Inc. 51.71 Million USD 48.013%
Relay Therapeutics, Inc. 91.97 Million USD 70.771%
Quoin Pharmaceuticals, Ltd. 6.5 Million USD -313.266%
Spero Therapeutics, Inc. 75.49 Million USD 64.39%
Artelo Biosciences, Inc. 1.02 Million USD -2533.105%
2seventy bio, Inc. 310.12 Million USD 91.331%
ADMA Biologics, Inc. 193.97 Million USD 86.141%
Clene Inc. 38.95 Million USD 30.98%
Capricor Therapeutics, Inc. 36.13 Million USD 25.597%
Boundless Bio, Inc. Common Stock 256.97 Million USD 89.538%
GeoVax Labs, Inc. 3.51 Million USD -663.776%
Recursion Pharmaceuticals, Inc. 190.26 Million USD 85.87%
Citius Pharmaceuticals, Inc. 12.17 Million USD -120.729%
Contineum Therapeutics, Inc. Class A Common Stock 198.32 Million USD 86.444%
Relmada Therapeutics, Inc. 12.19 Million USD -120.455%
Finch Therapeutics Group, Inc. 48.11 Million USD 44.121%
ALX Oncology Holdings Inc. 52.84 Million USD 49.123%
Vir Biotechnology, Inc. 369.85 Million USD 92.731%
Evaxion Biotech A/S 17.61 Million USD -52.598%
Ocular Therapeutix, Inc. 160.92 Million USD 83.294%
Verve Therapeutics, Inc. 153.18 Million USD 82.45%
Trevena, Inc. 48.26 Million USD 44.296%
Surrozen, Inc. 8.14 Million USD -230.068%
Tyra Biosciences, Inc. 21.59 Million USD -24.492%
Cingulate Inc. 10.36 Million USD -159.476%
Galmed Pharmaceuticals Ltd. 2.75 Million USD -877.6%
Unity Biotechnology, Inc. 37.29 Million USD 27.909%
Tenax Therapeutics, Inc. 3.58 Million USD -649.585%
Terns Pharmaceuticals, Inc. 13.15 Million USD -104.441%
ACADIA Pharmaceuticals Inc. 317.2 Million USD 91.525%
Connect Biopharma Holdings Limited 24.84 Million USD -8.189%
Clearmind Medicine Inc. 3.61 Million USD -644.707%
Kronos Bio, Inc. 54.2 Million USD 50.399%
Bolt Biotherapeutics, Inc. 47.04 Million USD 42.852%
CERo Therapeutics Holdings, Inc. 22.75 Million USD -18.121%
Viking Therapeutics, Inc. 20.07 Million USD -33.944%
Statera Biopharma, Inc. 22.67 Million USD -18.555%
ImmunityBio, Inc. 1.09 Billion USD 97.534%
Korro Bio, Inc. 51.75 Million USD 48.052%
Kineta, Inc. 7.22 Million USD -272.251%
BioVie Inc. 9.7 Million USD -177.094%
Codexis, Inc. 49.94 Million USD 46.174%
Celularity Inc. 102.92 Million USD 73.881%
Crinetics Pharmaceuticals, Inc. 96.24 Million USD 72.068%
Celcuity Inc. 51.45 Million USD 47.747%
Virax Biolabs Group Limited 345.19 Thousand USD -7688.084%
Cibus, Inc. 206.11 Million USD 86.957%
Eledon Pharmaceuticals, Inc. 42.47 Million USD 36.706%
eFFECTOR Therapeutics, Inc. 26.33 Million USD -2.069%
IN8bio, Inc. 8.77 Million USD -206.475%
Kodiak Sciences Inc. 213.59 Million USD 87.413%
Annexon, Inc. 47.11 Million USD 42.943%
Adverum Biotechnologies, Inc. 89.54 Million USD 69.976%
Assembly Biosciences, Inc. 96.37 Million USD 72.104%
Avalo Therapeutics, Inc. 13.68 Million USD -96.391%
Ionis Pharmaceuticals, Inc. 2.6 Billion USD 98.967%
Eyenovia, Inc. 19.78 Million USD -35.913%
Puma Biotechnology, Inc. 177.08 Million USD 84.819%
Conduit Pharmaceuticals Inc. 7.68 Million USD -250.007%
Xilio Therapeutics, Inc. 24.09 Million USD -11.556%
Arcellx, Inc. 339.75 Million USD 92.087%
Cardiff Oncology, Inc. 11.89 Million USD -125.954%
Enanta Pharmaceuticals, Inc. 245.54 Million USD 89.051%
Regulus Therapeutics Inc. 9.56 Million USD -181.125%
Moolec Science SA 13.94 Million USD -92.781%
Acumen Pharmaceuticals, Inc. 43.15 Million USD 37.699%
Geron Corporation 146.12 Million USD 81.602%
LAVA Therapeutics N.V. 50.53 Million USD 46.798%
Royalty Pharma plc 6.29 Billion USD 99.573%
Atea Pharmaceuticals, Inc. 39.77 Million USD 32.412%
Greenwich LifeSciences, Inc. 294.4 Thousand USD -9031.607%
TFF Pharmaceuticals, Inc. 2.46 Million USD -992.72%
Mersana Therapeutics, Inc. 189.15 Million USD 85.787%
Humacyte, Inc. 114.67 Million USD 76.557%
Structure Therapeutics Inc. 29.05 Million USD 7.459%
89bio, Inc. 59.96 Million USD 55.166%
PMV Pharmaceuticals, Inc. 26.46 Million USD -1.591%
Avenue Therapeutics, Inc. 1.19 Million USD -2147.826%
Genelux Corporation 8.42 Million USD -219.287%
Trevi Therapeutics, Inc. 6.85 Million USD -292.124%
Lexicon Pharmaceuticals, Inc. 136.31 Million USD 80.279%
Notable Labs, Ltd. 4.42 Million USD -507.274%
Liquidia Corporation 73.13 Million USD 63.242%
Mustang Bio, Inc. 17.61 Million USD -52.585%
Immunovant, Inc. 48.95 Million USD 45.084%
Quantum-Si incorporated 26.63 Million USD -0.95%
Arbutus Biopharma Corporation 38.38 Million USD 29.959%
DiaMedica Therapeutics Inc. 3.1 Million USD -766.387%
Vera Therapeutics, Inc. 73.86 Million USD 63.602%
Acasti Pharma Inc. 11.55 Million USD -132.621%
MiNK Therapeutics, Inc. 22.6 Million USD -18.915%
Pasithea Therapeutics Corp. 2.71 Million USD -888.962%
Xenon Pharmaceuticals Inc. 36.87 Million USD 27.098%
Elevai Labs, Inc. Common Stock 1.36 Million USD -1872.642%
NeuroBo Pharmaceuticals, Inc. 6.09 Million USD -341.01%
Tempest Therapeutics, Inc. 24.83 Million USD -8.25%
Soleno Therapeutics, Inc. 23.18 Million USD -15.959%
PepGen Inc. 34.63 Million USD 22.37%
Moleculin Biotech, Inc. 12.14 Million USD -121.377%
United Therapeutics Corporation 1.18 Billion USD 97.726%
Nuvectis Pharma, Inc. 6.98 Million USD -284.937%
Solid Biosciences Inc. 38.45 Million USD 30.095%
BriaCell Therapeutics Corp. 8.55 Million USD -214.168%
Immuneering Corporation 12 Million USD -123.877%
Lixte Biotechnology Holdings, Inc. 313.85 Thousand USD -8465.657%
Silo Pharma, Inc. 1.56 Million USD -1613.153%
Belite Bio, Inc 4.21 Million USD -538.423%
XOMA Corporation 145.58 Million USD 81.533%
ARS Pharmaceuticals, Inc. 2.42 Million USD -1007.249%
Bionomics Limited 10.15 Million USD -164.64%
Apogee Therapeutics, Inc. 21.49 Million USD -25.094%
Alpha Tau Medical Ltd. 22.91 Million USD -17.331%
uniQure N.V. 624.01 Million USD 95.692%
Cassava Sciences, Inc. 14.19 Million USD -89.391%
Estrella Immunopharma, Inc. 180.7 Thousand USD -14777.616%
Poseida Therapeutics, Inc. 170.18 Million USD 84.203%
Forte Biosciences, Inc. 3.66 Million USD -633.333%
Anebulo Pharmaceuticals, Inc. 260.58 Thousand USD -10216.866%
Enlivex Therapeutics Ltd. 6.74 Million USD -298.459%
Conduit Pharmaceuticals Inc. 7.68 Million USD -250.007%
SeaStar Medical Holding Corporation 17.38 Million USD -54.657%
FibroBiologics, Inc. Common Stock 10.56 Million USD -154.391%
Altimmune, Inc. 16.54 Million USD -62.529%
Amicus Therapeutics, Inc. 617.7 Million USD 95.648%
Alpha Tau Medical Ltd. 22.91 Million USD -17.331%
Compugen Ltd. 55.77 Million USD 51.799%
Peak Bio, Inc. 20.75 Million USD -29.54%
Zevra Therapeutics, Inc. 110.46 Million USD 75.662%
Benitec Biopharma Inc. 4.96 Million USD -441.798%
Spyre Therapeutics, Inc. 157.84 Million USD 82.968%
NKGen Biotech, Inc. Common Stock 75.17 Million USD 64.238%
Zura Bio Limited 21.29 Million USD -26.263%
PolyPid Ltd. 17.46 Million USD -53.904%
Aileron Therapeutics, Inc. 112.39 Million USD 76.082%
NKGen Biotech, Inc. Warrants 75.17 Million USD 64.238%
Instil Bio, Inc. 99.8 Million USD 73.062%
argenx SE 444.95 Million USD 93.958%
Immunome, Inc. 28.65 Million USD 6.19%
Compass Therapeutics, Inc. 8.33 Million USD -222.466%
Verona Pharma plc 58.84 Million USD 54.311%
enGene Holdings Inc. Warrants 14.47 Million USD -85.753%
Shattuck Labs, Inc. 14.85 Million USD -80.927%
CervoMed Inc. 2.59 Million USD -935.694%
LENZ Therapeutics, Inc. 4.87 Million USD -451.58%
Plus Therapeutics, Inc. 12.73 Million USD -111.087%
Dianthus Therapeutics, Inc. 10.53 Million USD -155.187%
Moolec Science SA 13.94 Million USD -92.781%
Enveric Biosciences, Inc. 2.34 Million USD -1047.171%
Inovio Pharmaceuticals, Inc. 55.59 Million USD 51.643%
AnaptysBio, Inc. 364.28 Million USD 92.62%
Design Therapeutics, Inc. 11.95 Million USD -124.858%
Leap Therapeutics, Inc. 12.68 Million USD -111.952%
NeurAxis, Inc. 1.91 Million USD -1305.524%
Seelos Therapeutics, Inc. 38.92 Million USD 30.939%
Lumos Pharma, Inc. 13.33 Million USD -101.635%
Achilles Therapeutics plc 19.08 Million USD -40.85%
enGene Holdings Inc. Common Stock 14.47 Million USD -85.753%
180 Life Sciences Corp. 5.38 Million USD -399.034%
Opiant Pharmaceuticals, Inc. 23.58 Million USD -13.973%
CERo Therapeutics Holdings, Inc. 22.75 Million USD -18.121%
Nutriband Inc. 1.07 Million USD -2391.753%
ORIC Pharmaceuticals, Inc. 30.59 Million USD 12.138%
CG Oncology, Inc. Common stock 14.51 Million USD -85.266%
Fractyl Health, Inc. Common Stock 401.27 Million USD 93.3%
Rani Therapeutics Holdings, Inc. 32.47 Million USD 17.211%
MoonLake Immunotherapeutics 13.04 Million USD -106.022%
Palisade Bio, Inc. 2.73 Million USD -881.526%
Tourmaline Bio, Inc. 5.25 Million USD -411.784%
Beam Therapeutics Inc. 478.38 Million USD 94.38%
Neurogene Inc. 36.54 Million USD 26.444%
Mirum Pharmaceuticals, Inc. 397.95 Million USD 93.244%
AEON Biopharma, Inc. 159.88 Million USD 83.186%
CARGO Therapeutics, Inc. Common Stock 47.65 Million USD 43.58%
Sesen Bio, Inc. 30.98 Million USD 13.233%
Enliven Therapeutics, Inc. 25.96 Million USD -3.555%
Kiora Pharmaceuticals, Inc. 7.6 Million USD -253.634%
Iovance Biotherapeutics, Inc. 195.73 Million USD 86.265%
Taysha Gene Therapies, Inc. 192.05 Million USD 86.002%
Athira Pharma, Inc. 30.05 Million USD 10.557%
Vaccinex, Inc. 5.94 Million USD -352.44%
HCW Biologics Inc. 15.05 Million USD -78.608%
XOMA Corporation 145.58 Million USD 81.533%
Nektar Therapeutics 267.04 Million USD 89.933%
Arvinas, Inc. 644.6 Million USD 95.829%
Tevogen Bio Holdings Inc. 17.73 Million USD -51.603%
Merus N.V. 102.15 Million USD 73.682%
Omega Therapeutics, Inc. 146.35 Million USD 81.63%
Quince Therapeutics, Inc. 95.12 Million USD 71.737%
Rezolute, Inc. 11.73 Million USD -129.112%
Clene Inc. 38.95 Million USD 30.98%
Indaptus Therapeutics, Inc. 2.84 Million USD -844.166%
BeyondSpring Inc. 48.26 Million USD 44.304%
Synlogic, Inc. 32.89 Million USD 18.273%
Allarity Therapeutics, Inc. 14.61 Million USD -83.973%
Phio Pharmaceuticals Corp. 1.63 Million USD -1545.288%
Peak Bio, Inc. 20.75 Million USD -29.54%
Werewolf Therapeutics, Inc. 63.45 Million USD 57.636%
Krystal Biotech, Inc. 39.71 Million USD 32.306%
Karyopharm Therapeutics Inc. 376.64 Million USD 92.862%
SpringWorks Therapeutics, Inc. 99.56 Million USD 73.0%
Lipella Pharmaceuticals Inc. 432.72 Thousand USD -6112.707%
MannKind Corporation 721.36 Million USD 96.273%
Ikena Oncology, Inc. 22.33 Million USD -20.367%
Cyclerion Therapeutics, Inc. 2.08 Million USD -1188.782%
Gyre Therapeutics, Inc. 102.59 Million USD 73.795%
Gossamer Bio, Inc. 249.14 Million USD 89.21%
CohBar, Inc. 1.03 Million USD -2500.911%
Cognition Therapeutics, Inc. 10.68 Million USD -151.511%
NRx Pharmaceuticals, Inc. 19.04 Million USD -41.138%
Legend Biotech Corporation 589.93 Million USD 95.443%
Mural Oncology plc 37.92 Million USD 29.118%
Biora Therapeutics, Inc. 132.63 Million USD 79.731%
PaxMedica, Inc. Common Stock 2.29 Million USD -1071.247%
Disc Medicine, Inc. 22.87 Million USD -17.526%
Champions Oncology, Inc. 28.03 Million USD 4.106%
REGENXBIO Inc. 262.22 Million USD 89.748%
Ensysce Biosciences, Inc. 3.35 Million USD -700.273%
Anavex Life Sciences Corp. 12.53 Million USD -114.489%
Cellectar Biosciences, Inc. 13.43 Million USD -100.154%
Edgewise Therapeutics, Inc. 21.2 Million USD -26.781%
Vaxart, Inc. 34.02 Million USD 20.988%
PharmaCyte Biotech, Inc. 20.38 Million USD -31.854%
Aldeyra Therapeutics, Inc. 28.53 Million USD 5.776%
Cellectis S.A. 249.57 Million USD 89.228%
Longeveron Inc. 5.33 Million USD -403.729%
Repare Therapeutics Inc. 41.81 Million USD 35.713%
Sarepta Therapeutics, Inc. 2.4 Billion USD 98.882%
Inozyme Pharma, Inc. 60.36 Million USD 55.466%
Revolution Medicines, Inc. 262.39 Million USD 89.754%
Nymox Pharmaceutical Corporation 2.1 Million USD -1175.937%
Third Harmonic Bio, Inc. 8.62 Million USD -211.662%
ArriVent BioPharma, Inc. Common Stock 11.8 Million USD -127.811%
AN2 Therapeutics, Inc. 14.04 Million USD -91.441%
Anixa Biosciences, Inc. 2.15 Million USD -1149.837%
Vertex Pharmaceuticals Incorporated 5.14 Billion USD 99.478%
Denali Therapeutics Inc. 122.96 Million USD 78.137%
Revelation Biosciences, Inc. 5.56 Million USD -383.1%
Veru Inc. 32.81 Million USD 18.068%
Corvus Pharmaceuticals, Inc. 6.86 Million USD -291.382%
Cingulate Inc. 10.36 Million USD -159.476%
Passage Bio, Inc. 39.26 Million USD 31.527%
Context Therapeutics Inc. 4.19 Million USD -541.36%
Exicure, Inc. 8.54 Million USD -214.47%
Day One Biopharmaceuticals, Inc. 29.5 Million USD 8.893%
Oramed Pharmaceuticals Inc. 10.48 Million USD -156.38%
Scinai Immunotherapeutics Ltd. 22.04 Million USD -21.973%
Rhythm Pharmaceuticals, Inc. 162.98 Million USD 83.505%
Nuvalent, Inc. 31.82 Million USD 15.52%
ABVC BioPharma, Inc. 6.36 Million USD -322.596%
Carisma Therapeutics, Inc. 63.02 Million USD 57.342%
Unicycive Therapeutics, Inc. 18 Million USD -49.356%
OmniAb, Inc. 87.4 Million USD 69.24%
Anew Medical, Inc. 8.24 Million USD -226.191%
Fennec Pharmaceuticals Inc. 38.28 Million USD 29.787%
Lipocine Inc. 2.63 Million USD -921.573%
Lexeo Therapeutics, Inc. Common Stock 26.27 Million USD -2.329%
Nautilus Biotechnology, Inc. 40.21 Million USD 33.144%
SAB Biotherapeutics, Inc. 26.64 Million USD -0.909%
G1 Therapeutics, Inc. 86.15 Million USD 68.795%
Bellerophon Therapeutics, Inc. 5.4 Million USD -397.76%
Sage Therapeutics, Inc. 82.74 Million USD 67.511%
Ocugen, Inc. 23.98 Million USD -12.096%
Mind Medicine (MindMed) Inc. 46.4 Million USD 42.069%
Q32 Bio Inc. 233.12 Million USD 88.468%
Brainstorm Cell Therapeutics Inc. 9.06 Million USD -196.537%
Alumis Inc. Common Stock 53.5 Million USD 49.751%
Equillium, Inc. 27.95 Million USD 3.838%
Kyverna Therapeutics, Inc. 206.59 Million USD 86.987%
Coya Therapeutics, Inc. 5.62 Million USD -377.796%
CNS Pharmaceuticals, Inc. 6.13 Million USD -338.352%
Galera Therapeutics, Inc. 157.32 Million USD 82.912%
Evelo Biosciences, Inc. 69.43 Million USD 61.281%
Comera Life Sciences Holdings, Inc. 9.97 Million USD -169.535%
Dominari Holdings Inc. 4.63 Million USD -480.022%
Edesa Biotech, Inc. 1.84 Million USD -1359.788%
vTv Therapeutics Inc. 29.56 Million USD 9.074%
Bio-Techne Corporation 744.34 Million USD 96.388%
Agios Pharmaceuticals, Inc. 126.09 Million USD 78.68%
Harmony Biosciences Holdings, Inc. 344.45 Million USD 92.195%
Prelude Therapeutics Incorporated 40.57 Million USD 33.742%
Candel Therapeutics, Inc. 28.95 Million USD 7.159%
iTeos Therapeutics, Inc. 92.36 Million USD 70.892%
Nkarta, Inc. 105.6 Million USD 74.542%
BioCardia, Inc. 4.59 Million USD -485.708%
Iterum Therapeutics plc 32.66 Million USD 17.69%